Histogen

Developer of small molecule caspase inhibitors to restore immune function against infectious and inflammatory diseases

placeSan Diego, California, United States calendar_todayFounded 2007 groups22 employees language histogen.com

Registered entities

Innovation

16 patent families (8 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 1,173 times.

YearFilings
20142
20153
20163
20173
20184
20195
20205
20215
20227
20232
20241
20251

Investor mix

4 investors on record; lead investors include Secure Medical.

Investor typeCountShare
Other / undisclosed4100%
Coming soon